These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24140556)

  • 1. A bacterium's guide to orienteering in the intestinal lumen. Interview by Emma Louise Walton.
    Jang YS
    Microbes Infect; 2013 Nov; 15(13):845-8. PubMed ID: 24140556
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing Salmonella for antigen delivery: the aims and benefits of bacterial delivered vaccination.
    Kong W; Clark-Curtiss J; Curtiss R
    Expert Rev Vaccines; 2013 Apr; 12(4):345-7. PubMed ID: 23560914
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosal immunisation: Successful approaches to targeting different tissues.
    Ferro VA; Carter KC
    Methods; 2006 Feb; 38(2):61-4. PubMed ID: 16442812
    [No Abstract]   [Full Text] [Related]  

  • 5. The intestinal immune system and oral vaccination.
    Newby TJ; Stokes CR
    Vet Immunol Immunopathol; 1984 May; 6(1-2):67-105. PubMed ID: 6204436
    [No Abstract]   [Full Text] [Related]  

  • 6. Lectins and microparticles for enhanced oral vaccination.
    Lavelle EC
    Methods; 2006 Feb; 38(2):84-9. PubMed ID: 16406570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination by inducing oral tolerance?
    McSorley SJ; Garside P
    Immunol Today; 1999 Dec; 20(12):555-60. PubMed ID: 10562706
    [No Abstract]   [Full Text] [Related]  

  • 8. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
    Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination markers: designing unique antigens to be added to vaccines to differentiate between natural infection and vaccination.
    Root-Bernstein RS
    Vaccine; 2005 Mar; 23(17-18):2057-9. PubMed ID: 15755570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.
    Devriendt B; De Geest BG; Goddeeris BM; Cox E
    J Control Release; 2012 Jun; 160(3):431-9. PubMed ID: 22353618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric pathogens as vaccine vectors for foreign antigen delivery.
    Kotton CN; Hohmann EL
    Infect Immun; 2004 Oct; 72(10):5535-47. PubMed ID: 15385450
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigen uptake and immune responses after oral vaccination.
    Quentel C; Vigneulle M
    Dev Biol Stand; 1997; 90():69-78. PubMed ID: 9270836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting receptor biology for oral vaccination with biodegradable particulates.
    Foster N; Hirst BH
    Adv Drug Deliv Rev; 2005 Jan; 57(3):431-50. PubMed ID: 15560950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells?
    Kaiserlian D; Etchart N
    Semin Immunol; 1999 Jun; 11(3):217-24. PubMed ID: 10381867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut-associated lymphoid tissues for the development of oral vaccines.
    Kunisawa J; Kurashima Y; Kiyono H
    Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gut response to vaccines.
    von Bubnoff A
    IAVI Rep; 2011; 15(6):12-4. PubMed ID: 22351962
    [No Abstract]   [Full Text] [Related]  

  • 20. Anatomical basis of tolerance and immunity to intestinal antigens.
    Mowat AM
    Nat Rev Immunol; 2003 Apr; 3(4):331-41. PubMed ID: 12669023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.